PulmOne Company

"Desktop Device for Pulmonary Function Testing."

PulmOne develops patient-friendly, hassle-free, and budget-conscious devices designed to accurately inform clinical decision making throughout the diagnosis, treatment, and monitoring of respiratory diseases.
The company's MiniBox is a system for measuring lung volume and spirometry. It is a desktop device designed to provide an accurate assessment of lung volume based on normal tidal breathing and a short measurement time. The system does not rely on a plethysmograph or external gas source.
PulmOne's MiniBox+ adds to the spirometry and LVM tests with a diffusing capacity (DLCO) module, providing a complete solution.
The company has received FDA 510k clearance and a CE mark for its first product and started sales in several locations.

Combating Coronavirus Pandemic:
PulmOne's solution helps address the Coronavirus Pandemic. PulmOne developed a desktop device for pulmonary lung measurements and function testing. Its tech can be used for pulmonary function screening of patients “who may have contracted the COVID-19 virus, in particular, to determine who may get priority for hard-to-find ventilation,” according to the company which participated in a webinar hosted by OurCrowd last week.
Technology: COVID Treatments
Industry: HealthTech
Headquarters: Israel
Founded Date: 2006
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership